MITech Co Ltd
MITech Co Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.
Business. MITech Co Ltd (179290.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is listed on the KOSDAQ exchange.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MITech Co Ltd (179290.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is listed on the KOSDAQ exchange.
MITech Co Ltd maintains a strong liquidity position, with a current ratio of 9.65 and cash and equivalents amounting to 19,964,226,330 KRW, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal reliance on debt financing. This low leverage supports financial stability and flexibility in capital allocation.
In terms of profitability, MITech's return on equity (ROE) is 5.85%, and its return on assets (ROA) is 5.3%, both of which are strong indicators of efficient asset utilization and profitability. These metrics align with the industry's preferred performance indicators, suggesting that the company is performing in line with or above the industry median.
Geographically and segment-wise, MITech's revenue concentration is not disclosed in the available data, but the company operates in the healthcare services and equipment sector, which is typically less sensitive to geographic volatility. The company's business model is centered around medical equipment and supplies, with a focus on distribution and services.
Looking at growth, MITech's recent financial performance shows a revenue of 13,268,568,710 KRW and a net income of 5,626,669,410 KRW. While specific growth projections for the next fiscal year are not provided, the company's strong operating cash flow of 5,944,376,970 KRW and free cash flow of 5,831,781,830 KRW suggest a solid foundation for future expansion.
Risk factors for MITech are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's low debt levels and strong liquidity position reduce the risk of financial distress. Additionally, the absence of dilution potential in the near term supports investor confidence.
Recent events, including the latest actual EPS of 628.00 KRW and revenue of 67,151,800,000 KRW, indicate consistent performance. These figures align with the company's reported financials and suggest that MITech is meeting or exceeding analyst expectations.
- MITech Co Ltd has a strong liquidity position with a current ratio of 9.65 and minimal debt.
- The company's ROE of 5.85% and ROA of 5.3% indicate efficient asset utilization and profitability.
- No immediate liquidity or dilution risks are present, supporting a stable financial outlook.
- Strong operating and free cash flows suggest a solid foundation for future growth.
- The company's performance aligns with or exceeds analyst expectations, as reflected in recent EPS and revenue figures.
Bull / Bear case
Generated · model-assistedWith a debt-to-equity ratio of 0.01, MITech maintains a highly conservative capital structure well below the 0.20 cohort median.
Cash conversion of 1.06 exceeds the 0.84 cohort median, indicating efficient translation of operating income into free cash flow.
Low dilution, liquidity, and credit risk flags suggest a stable financial profile with minimal immediate threats to shareholder value.
The four-year revenue CAGR of -2.0% suggests a long-term structural decline in the company's market presence or demand.
In focus — financials by report
Revenue KRW 17.18B, +40,4% YoY; Operating income +82,2% YoY.
- ▍Revenue KRW 17.18B, +40,4% YoY
- ▍Operating income +82,2% YoY
- ▍Net income +44,5% YoY
- ▍Free cash flow +20,5% YoY
- ▍Net margin 29.8%
Revenue KRW 17.06B, +10,5% YoY; Operating income −4,3% YoY.
- ▍Revenue KRW 17.06B, +10,5% YoY
- ▍Operating income −4,3% YoY
- ▍Net income +13,5% YoY
- ▍Free cash flow +1,2% YoY
- ▍Net margin 29.0%
Revenue KRW 15.67B, +22,4% YoY; Operating income +6,2% YoY.
- ▍Revenue KRW 15.67B, +22,4% YoY
- ▍Operating income +6,2% YoY
- ▍Net income −6,4% YoY
- ▍Free cash flow −41,8% YoY
- ▍Net margin 28.5%
Revenue KRW 17.25B, +30,0% YoY; Operating income +22,6% YoY.
- ▍Revenue KRW 17.25B, +30,0% YoY
- ▍Operating income +22,6% YoY
- ▍Net income +3,2% YoY
- ▍Free cash flow +2,3% YoY
- ▍Net margin 33.7%
Revenue KRW 12.24B; Operating income KRW 2.30B.
- ▍Revenue KRW 12.24B
- ▍Operating income KRW 2.30B
- ▍Net margin 29.0%
Revenue KRW 15.44B; Operating income KRW 6.01B.
- ▍Revenue KRW 15.44B
- ▍Operating income KRW 6.01B
- ▍Net margin 28.2%
Revenue KRW 12.80B; Operating income KRW 3.83B.
- ▍Revenue KRW 12.80B
- ▍Operating income KRW 3.83B
- ▍Net margin 37.2%
Revenue KRW 13.27B; Operating income KRW 5.44B.
- ▍Revenue KRW 13.27B
- ▍Operating income KRW 5.44B
- ▍Net margin 42.4%
Revenue KRW 67.15B, +24,9% YoY; Operating income +16,3% YoY.
- ▍Revenue KRW 67.15B, +24,9% YoY
- ▍Operating income +16,3% YoY
- ▍Net income +11,2% YoY
- ▍Free cash flow −10,7% YoY
- ▍Net margin 30.3%
Revenue KRW 53.75B, +15,9% YoY; Operating income +25,0% YoY.
- ▍Revenue KRW 53.75B, +15,9% YoY
- ▍Operating income +25,0% YoY
- ▍Net income +42,9% YoY
- ▍Free cash flow +64,8% YoY
- ▍Net margin 34.0%
Revenue KRW 56.22B, +11,9% YoY; Operating income +72,4% YoY.
- ▍Revenue KRW 56.22B, +11,9% YoY
- ▍Operating income +72,4% YoY
- ▍Net income +56,4% YoY
- ▍Free cash flow +82,8% YoY
- ▍Net margin 34.1%
Revenue KRW 50.26B; Operating income KRW 12.93B.
- ▍Revenue KRW 50.26B
- ▍Operating income KRW 12.93B
- ▍Net margin 24.4%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- MITech Co Ltd Market data — financials · 2026-05-26
- MITech Co Ltd Market data — analyst estimates · 2026-05-26